Pablo Cabello-García
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pablo Cabello-García has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Viñals
Department of Medical Physics, Clínica Universidad de Navarra, 28027 Madrid, Spain
2 shared publications - Ana Maria Romero
CIEMAT, Radiation Dosimetry , Avda Complutense 40, 28040 Madrid, Spain
2 shared publications - Carles Domingo
Universitat Autónoma de Barcelona
2 shared publications - Evangelina Martínez-Francés
Clinica Universidad de Navarra
2 shared publications - Javier Burguete
Department of Physics and Applied Mathematics, University of Navarra, Pamplona, Spain
2 shared publications - Rafael Rodriguez
CIEMAT
2 shared publications
Latest Publications
- Open Access
- 6 August 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (15) , 15TR01
A systematic review on the clinical implementation of 4D particle therapy
Intrafractional motion in the thoracic and abdominal regions remains a major challenge in particle therapy representing one of the key anatomical changes during radiotherapy. Interfractional changes further contribute to cumulative uncertainties and may require adaptive strategies over the course of treatment. The high dose conformality and steep dose fall-off of particle beams, combined with motion-induced range variations, make dose delivery highly sensitive to temporal and anatomical changes. This systematic review provides an overview of clinically implemented 4D treatment approaches addressing intrafractional motion for thoracic and abdominal indications, aiming to support harmonisation of clinical practices across centres and vendors. Systematic searches in PubMed and Web of Science identified relevant publications from January 2020 to December 2025 covering the full 4D workflow in particle therapy. The focus was on clinical implementation for lung, pancreas, liver, lymphoma, oesophagus, and breast, complemented by phantom studies and ongoing research activities. Publications were screened by eight experts using predefined inclusion and exclusion criteria. Writing and synthesis were conducted by a multidisciplinary panel of eighteen experts. A total of 751 publications were identified, of which 231 were included and categorised into six key subtopics: motion management, imaging, treatment planning optimisation and evaluation, clinical indications, phantom studies, and future perspectives. The results confirm that intrafractional motion remains a major source of uncertainty across the workflow. Despite numerous proposed 4D techniques, clinical implementation varies widely. A key limitation is the lack of standardised methods for 4D dose evaluation and interplay assessment, particularly relevant for hypofractionated treatments and advanced delivery techniques. Increasing clinical experience demonstrates that motion-related challenges can be effectively managed using appropriate 4D-aware workflows. This review represents an important step towards establishing consensus and developing guidelines for treating moving targets in particle therapy.
- 6 August 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (15) , 15TR01
Open AccessA systematic review on the clinical implementation of 4D particle therapy
Intrafractional motion in the thoracic and abdominal regions remains a major challenge in particle therapy representing one of the key anatomical changes during radiotherapy. Interfractional changes further contribute to cumulative uncertainties and may require adaptive strategies over the course of treatment. The high dose conformality and steep dose fall-off of particle beams, combined with motion-induced range variations, make dose delivery highly sensitive to temporal and anatomical changes. This systematic review provides an overview of clinically implemented 4D treatment approaches addressing intrafractional motion for thoracic and abdominal indications, aiming to support harmonisation of clinical practices across centres and vendors. Systematic searches in PubMed and Web of Science identified relevant publications from January 2020 to December 2025 covering the full 4D workflow in particle therapy. The focus was on clinical implementation for lung, pancreas, liver, lymphoma, oesophagus, and breast, complemented by phantom studies and ongoing research activities. Publications were screened by eight experts using predefined inclusion and exclusion criteria. Writing and synthesis were conducted by a multidisciplinary panel of eighteen experts. A total of 751 publications were identified, of which 231 were included and categorised into six key subtopics: motion management, imaging, treatment planning optimisation and evaluation, clinical indications, phantom studies, and future perspectives. The results confirm that intrafractional motion remains a major source of uncertainty across the workflow. Despite numerous proposed 4D techniques, clinical implementation varies widely. A key limitation is the lack of standardised methods for 4D dose evaluation and interplay assessment, particularly relevant for hypofractionated treatments and advanced delivery techniques. Increasing clinical experience demonstrates that motion-related challenges can be effectively managed using appropriate 4D-aware workflows. This review represents an important step towards establishing consensus and developing guidelines for treating moving targets in particle therapy.
- Open Access
Salvage Proton Therapy Re-Irradiation in Recurrent Head and Neck Cancer: Outcomes and Adverse Events by Re-Irradiated Target Site
Background/Objectives: Photon re-irradiation in previously treated head and neck cancer (HNC) is constrained by cumulative normal-tissue toxicity. Pencil-beam scanning intensity-modulated proton therapy (PBS-IMPT) allows for a sharper dose conformation than conventional photon techniques, which may widen the therapeutic window in previously irradiated tissue. Methods: Sixty-five patients with recurrent or second primary HNC were enrolled in a prospective single-institution registry and re-irradiated with PBS-IMPT between January 2020 and December 2025. Forty-five were treated with radical intent (69.2%), and 20 were treated postoperatively (30.8%), with a median prescribed dose of 66 Gy (RBE) in 30 fractions. Primary endpoints were overall survival (OS) and progression-free survival (PFS). Locoregional control (LRC), adverse events and the prognostic impact of anatomical extent were secondary endpoints. Results: The median follow-up was 9.3 months. The median OS was 17.2 months (95% CI 13.9–NR), with a 12-month rate of 67.1%. The median PFS was 10.1 months and the median LRC was 28.1 months. Central/skull-base involvement was associated with a non-significant trend toward worse OS (14.3 vs. 35.2 months; p = 0.062) and with significantly worse PFS (9.1 vs. 14.7 months; p = 0.037) than peripheral disease, but LRC did not differ between the groups (p = 0.240). Grade ≥ 3 oral mucositis occurred in 7.7%, with no grade 4–5 acute events. Within a median follow-up of 9.3 months, late osteoradionecrosis affected 6.2%, but late toxicity data remain preliminary given the short follow-up. Ninety-two percent of patients completed treatment. Conclusions: PBS-IMPT re-irradiation provided adequate survival with low acute toxicity. T3–T4 stage at re-irradiation was the only variable retaining significance for PFS on multivariable analysis (HR 4.32, 95% CI 1.24–15.13; p = 0.022). The poor survival observed for central/skull-base disease on Kaplan–Meier curves disappeared after T-stage adjustment, indicating the higher concentration of advanced disease in that compartment. Multicentre prospective data and longer follow-up are needed.
Open AccessSalvage Proton Therapy Re-Irradiation in Recurrent Head and Neck Cancer: Outcomes and Adverse Events by Re-Irradiated Target Site
Background/Objectives: Photon re-irradiation in previously treated head and neck cancer (HNC) is constrained by cumulative normal-tissue toxicity. Pencil-beam scanning intensity-modulated proton therapy (PBS-IMPT) allows for a sharper dose conformation than conventional photon techniques, which may widen the therapeutic window in previously irradiated tissue. Methods: Sixty-five patients with recurrent or second primary HNC were enrolled in a prospective single-institution registry and re-irradiated with PBS-IMPT between January 2020 and December 2025. Forty-five were treated with radical intent (69.2%), and 20 were treated postoperatively (30.8%), with a median prescribed dose of 66 Gy (RBE) in 30 fractions. Primary endpoints were overall survival (OS) and progression-free survival (PFS). Locoregional control (LRC), adverse events and the prognostic impact of anatomical extent were secondary endpoints. Results: The median follow-up was 9.3 months. The median OS was 17.2 months (95% CI 13.9–NR), with a 12-month rate of 67.1%. The median PFS was 10.1 months and the median LRC was 28.1 months. Central/skull-base involvement was associated with a non-significant trend toward worse OS (14.3 vs. 35.2 months; p = 0.062) and with significantly worse PFS (9.1 vs. 14.7 months; p = 0.037) than peripheral disease, but LRC did not differ between the groups (p = 0.240). Grade ≥ 3 oral mucositis occurred in 7.7%, with no grade 4–5 acute events. Within a median follow-up of 9.3 months, late osteoradionecrosis affected 6.2%, but late toxicity data remain preliminary given the short follow-up. Ninety-two percent of patients completed treatment. Conclusions: PBS-IMPT re-irradiation provided adequate survival with low acute toxicity. T3–T4 stage at re-irradiation was the only variable retaining significance for PFS on multivariable analysis (HR 4.32, 95% CI 1.24–15.13; p = 0.022). The poor survival observed for central/skull-base disease on Kaplan–Meier curves disappeared after T-stage adjustment, indicating the higher concentration of advanced disease in that compartment. Multicentre prospective data and longer follow-up are needed.
- Open Access
- 18 June 2026
- Published by Elsevier in Physica Medica
- Vol. 148, 105842
Patient-specific assessment of dosimetric deformable registration uncertainties and respiratory motion effects for moving tumours in proton therapy
- 18 June 2026
- Published by Elsevier in Physica Medica
- Vol. 148, 105842
Open AccessPatient-specific assessment of dosimetric deformable registration uncertainties and respiratory motion effects for moving tumours in proton therapy
- Open Access
- 26 May 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (11)
Out-of-field neutron doses in proton therapy: from experimental characterization to a practical calculation tool
Objective: To experimentally characterize out-of-field neutron dose in a pencil beam scanning (PBS) proton therapy treatment room using multiple detectors, to analyze its dependence on proton energy, gantry angle, distance to isocenter, and field size, and to develop a practical calculation tool for neutron dose estimation. Approach: Two extended-range ambient detectors, bubble (BDs) detectors, track-etch, thermoluminescent (TLDs), and three electronic personal dosimeters were used. Measurements were taken at up to 21 points for five proton energies, four gantry angles (ϴ), four field sizes, four measurement lines, and distances of 1-4.7 m from the isocenter. Room symmetry was evaluated. At each point, H*(10) or Hp(10) = a·E p b was assessed, and measurements were also performed for a clinical irradiation, with the resulting doses compared against weighted sums of contributions from individual energy layers. Bland-Altman analyses were applied. Main results: The room was symmetric for ϴ = 270º-90º, while doses at 0º were on average 8% lower than at 180º. Neutron doses for the spot field and 10 × 10 cm 2 field were interchangeable, with 20 × 20 and 30 × 30 cm 2 fields differing by 2-22%. Dose dependence on proton energy followed a power-law, with best fits for ambient detectors and moderate performance for BDs and TLDs. Linear superposition held for ambient and BDs, validating that neutron doses can be approximated as weighted sums of contributions from individual energy layers. A Python-based calculator for out-of-field neutron doses, provided as supplementary material, was developed for six detectors. Significance: This study delivers an easy-to-use Python tool for first-order estimation of out-of-field neutron doses in a PBS proton therapy room for any treatment plan or location. The tool is based on the linear superposition model, is validated against measurements, and accounts for detector-dependent uncertainties.
- 26 May 2026
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 71 (11)
Open AccessOut-of-field neutron doses in proton therapy: from experimental characterization to a practical calculation tool
Objective: To experimentally characterize out-of-field neutron dose in a pencil beam scanning (PBS) proton therapy treatment room using multiple detectors, to analyze its dependence on proton energy, gantry angle, distance to isocenter, and field size, and to develop a practical calculation tool for neutron dose estimation. Approach: Two extended-range ambient detectors, bubble (BDs) detectors, track-etch, thermoluminescent (TLDs), and three electronic personal dosimeters were used. Measurements were taken at up to 21 points for five proton energies, four gantry angles (ϴ), four field sizes, four measurement lines, and distances of 1-4.7 m from the isocenter. Room symmetry was evaluated. At each point, H*(10) or Hp(10) = a·E p b was assessed, and measurements were also performed for a clinical irradiation, with the resulting doses compared against weighted sums of contributions from individual energy layers. Bland-Altman analyses were applied. Main results: The room was symmetric for ϴ = 270º-90º, while doses at 0º were on average 8% lower than at 180º. Neutron doses for the spot field and 10 × 10 cm 2 field were interchangeable, with 20 × 20 and 30 × 30 cm 2 fields differing by 2-22%. Dose dependence on proton energy followed a power-law, with best fits for ambient detectors and moderate performance for BDs and TLDs. Linear superposition held for ambient and BDs, validating that neutron doses can be approximated as weighted sums of contributions from individual energy layers. A Python-based calculator for out-of-field neutron doses, provided as supplementary material, was developed for six detectors. Significance: This study delivers an easy-to-use Python tool for first-order estimation of out-of-field neutron doses in a PBS proton therapy room for any treatment plan or location. The tool is based on the linear superposition model, is validated against measurements, and accounts for detector-dependent uncertainties.
- Open Access
- 19 July 2025
- Published by Elsevier in Physica Medica
- Vol. 136, 105044
Intercomparison of personal and ambient neutron detectors used for radiation protection in a synchrotron-based proton therapy facility: experimental and Monte Carlo results
- 19 July 2025
- Published by Elsevier in Physica Medica
- Vol. 136, 105044
Open AccessIntercomparison of personal and ambient neutron detectors used for radiation protection in a synchrotron-based proton therapy facility: experimental and Monte Carlo results